Halving time at 3 months was the only independent predictor of outcome among patients with >10% BCR-ABL1
| Halving time at 3 months . | OS hazard ratio . | P value . | PFS hazard ratio . | P value . | FFS hazard ratio . | P value . | MMR relative risk . | P value . |
|---|---|---|---|---|---|---|---|---|
| ≤76 days | 1 | .013 | 1 | .009 | 1 | < .0001 | 1 | .012 |
| >76 days | 6.6 (1.49-29.6) | 5.23 (1.50-18.2) | 6.75 (3.51-13.0) | 0.08 (0.01-0.57) |
| Halving time at 3 months . | OS hazard ratio . | P value . | PFS hazard ratio . | P value . | FFS hazard ratio . | P value . | MMR relative risk . | P value . |
|---|---|---|---|---|---|---|---|---|
| ≤76 days | 1 | .013 | 1 | .009 | 1 | < .0001 | 1 | .012 |
| >76 days | 6.6 (1.49-29.6) | 5.23 (1.50-18.2) | 6.75 (3.51-13.0) | 0.08 (0.01-0.57) |